161 related articles for article (PubMed ID: 26990535)
1. miR-203 and miR-221 regulate SOCS1 and SOCS3 in essential thrombocythemia.
Navarro A; Pairet S; Álvarez-Larrán A; Pons A; Ferrer G; Longarón R; Fernández-Rodríguez C; Camacho L; Monzó M; Besses C; Bellosillo B
Blood Cancer J; 2016 Mar; 6(3):e406. PubMed ID: 26990535
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of PIAS1 and PIAS3 in essential thrombocythemia patients.
Hsiao HH; Liu YC; Yang MY; Tsai YF; Liu TC; Chang CS; Lin SF
Genet Mol Res; 2013 Nov; 12(4):5617-22. PubMed ID: 24301930
[TBL] [Abstract][Full Text] [Related]
3. JAK2V617F-negative ET patients do not display constitutively active JAK/STAT signaling.
Schwemmers S; Will B; Waller CF; Abdulkarim K; Johansson P; Andreasson B; Pahl HL
Exp Hematol; 2007 Nov; 35(11):1695-703. PubMed ID: 17764814
[TBL] [Abstract][Full Text] [Related]
4. miR-19a: an effective regulator of SOCS3 and enhancer of JAK-STAT signalling.
Collins AS; McCoy CE; Lloyd AT; O'Farrelly C; Stevenson NJ
PLoS One; 2013; 8(7):e69090. PubMed ID: 23894411
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms.
Gao SM; Chen CQ; Wang LY; Hong LL; Wu JB; Dong PH; Yu FJ
Exp Hematol; 2013 Mar; 41(3):261-70.e4. PubMed ID: 23111066
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling distinguishes JAK2V617F-negative from JAK2V617F-positive patients in essential thrombocythemia.
Puigdecanet E; Espinet B; Lozano JJ; Sumoy L; Bellosillo B; Arenillas L; Alvarez-Larrán A; Solé F; Serrano S; Besses C; Florensa L
Leukemia; 2008 Jul; 22(7):1368-76. PubMed ID: 18480837
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders.
Capello D; Deambrogi C; Rossi D; Lischetti T; Piranda D; Cerri M; Spina V; Rasi S; Gaidano G; Lunghi M
Br J Haematol; 2008 May; 141(4):504-11. PubMed ID: 18318760
[TBL] [Abstract][Full Text] [Related]
8. The clinical impact of DNA methylation frequencies of JAK2 negative regulators in patients with essential thrombocythemia.
Födermayr M; Zach O; Huber M; Machherndl-Spandl S; Wölfl S; Bösmüller HC; Hasenschwandtner S; Burgstaller S; Krieger O; Lutz D; Weltermann A; Hauser H
Leuk Res; 2012 May; 36(5):588-90. PubMed ID: 22325365
[TBL] [Abstract][Full Text] [Related]
9. Silencing microRNA-221/222 cluster suppresses glioblastoma angiogenesis by suppressor of cytokine signaling-3-dependent JAK/STAT pathway.
Xu CH; Liu Y; Xiao LM; Chen LK; Zheng SY; Zeng EM; Li DH; Li YP
J Cell Physiol; 2019 Dec; 234(12):22272-22284. PubMed ID: 31106423
[TBL] [Abstract][Full Text] [Related]
10. Expression analysis of microRNA-125 in patients with polycythemia vera and essential thrombocythemia and correlation with JAK2 allele burden and laboratory findings.
Ferdowsi S; Atarodi K; Amirizadeh N; Toogeh G; Azarkeivan A; Shirkoohi R; Faranoush M; Vaezi M; Alimoghaddam K; Ghavamzadeh A; Naghadeh HT; Ghaffari SH
Int J Lab Hematol; 2015 Oct; 37(5):661-7. PubMed ID: 26011312
[TBL] [Abstract][Full Text] [Related]
11. Respiratory Syncytial Virus Nonstructural Proteins Upregulate SOCS1 and SOCS3 in the Different Manner from Endogenous IFN Signaling.
Zheng J; Yang P; Tang Y; Pan Z; Zhao D
J Immunol Res; 2015; 2015():738547. PubMed ID: 26557722
[TBL] [Abstract][Full Text] [Related]
12. MiR-221 accentuates IFN׳s anti-HCV effect by downregulating SOCS1 and SOCS3.
Xu G; Yang F; Ding CL; Wang J; Zhao P; Wang W; Ren H
Virology; 2014 Aug; 462-463():343-50. PubMed ID: 25019494
[TBL] [Abstract][Full Text] [Related]
13. The JAK-STAT signaling pathway is differentially activated in CALR-positive compared with JAK2V617F-positive ET patients.
Lau WW; Hannah R; Green AR; Göttgens B
Blood; 2015 Mar; 125(10):1679-81. PubMed ID: 25745188
[No Abstract] [Full Text] [Related]
14. Platelet microRNA expression and association with platelet maturity and function in patients with essential thrombocythemia.
Tran JQD; Pedersen OH; Larsen ML; Grove EL; Kristensen SD; Hvas AM; Nissen PH
Platelets; 2020; 31(3):365-372. PubMed ID: 31240987
[TBL] [Abstract][Full Text] [Related]
15. Pure curcumin increases the expression of SOCS1 and SOCS3 in myeloproliferative neoplasms through suppressing class I histone deacetylases.
Chen CQ; Yu K; Yan QX; Xing CY; Chen Y; Yan Z; Shi YF; Zhao KW; Gao SM
Carcinogenesis; 2013 Jul; 34(7):1442-9. PubMed ID: 23430957
[TBL] [Abstract][Full Text] [Related]
16. miR-19b downregulates intestinal SOCS3 to reduce intestinal inflammation in Crohn's disease.
Cheng X; Zhang X; Su J; Zhang Y; Zhou W; Zhou J; Wang C; Liang H; Chen X; Shi R; Zen K; Zhang CY; Zhang H
Sci Rep; 2015 May; 5():10397. PubMed ID: 25997679
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic deregulated miR-375 contributes to the constitutive activation of JAK2/STAT signaling in myeloproliferative neoplasm.
Yin LH; Zheng XQ; Li HY; Bi LX; Shi YF; Ye AF; Wu JB; Gao SM
Leuk Res; 2015 Apr; 39(4):471-8. PubMed ID: 25666256
[TBL] [Abstract][Full Text] [Related]
18. MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis.
Pathak S; Grillo AR; Scarpa M; Brun P; D'Incà R; Nai L; Banerjee A; Cavallo D; Barzon L; Palù G; Sturniolo GC; Buda A; Castagliuolo I
Exp Mol Med; 2015 May; 47(5):e164. PubMed ID: 25998827
[TBL] [Abstract][Full Text] [Related]
19. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.
Ortiz-Muñoz G; Martin-Ventura JL; Hernandez-Vargas P; Mallavia B; Lopez-Parra V; Lopez-Franco O; Muñoz-Garcia B; Fernandez-Vizarra P; Ortega L; Egido J; Gomez-Guerrero C
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):525-31. PubMed ID: 19164812
[TBL] [Abstract][Full Text] [Related]
20. MiR-122 modulates type I interferon expression through blocking suppressor of cytokine signaling 1.
Li A; Song W; Qian J; Li Y; He J; Zhang Q; Li W; Zhai A; Kao W; Hu Y; Li H; Wu J; Ling H; Zhong Z; Zhang F
Int J Biochem Cell Biol; 2013 Apr; 45(4):858-65. PubMed ID: 23348614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
